Materion (MTRN) Q3 2025 earnings summary

Executive summary

• Net sales for Q3 2025 were $444.8 million, up 2% year-over-year, with value-added sales of $263.9 million, reflecting 1% organic growth despite equipment downtime in Performance Materials.

• Net income rose 14% to $25.4 million ($1.22 per diluted share), with adjusted EPS flat at $1.41 year-over-year and operating profit up to $34.9 million.

• Record EBITDA margins of 27.1% in Electronic Materials and 1000 basis points margin expansion in Precision Optics, driven by semiconductor recovery and new business wins.

• Order rates increased double digits sequentially across all business segments, with record defense bookings and a new supply agreement for fusion energy technology.

• Announced a new $50 million stock repurchase program and continued transformation in Precision Optics.

Financial highlights

• Value-added sales for Q3 were $263.9 million, up 1% organically year-over-year; net income was $25.4 million (5.7% of net sales).

• Adjusted EPS was $1.41, flat year-over-year and up 3% sequentially; adjusted EBITDA was $55.5 million (21.0% of value-added sales).

• Gross margin for Q3 was $86.1 million (19% of net sales), up 6% year-over-year; operating profit rose 12% to $34.9 million.

• Net debt at quarter-end was $441 million, with leverage at 2x, within target range.

• Cash flow from operations for the first nine months was $83.7 million, up from $11.6 million year-over-year.

Outlook and guidance

• Full-year adjusted EPS guidance affirmed at $5.30–$5.70, with strong order rates and new business initiatives supporting momentum into 2026.

• Management expects significant improvement in Q4 as equipment issues are resolved and defense/energy sales rise.

• Capital expenditures for 2025 expected to be approximately $70 million.

• Liquidity remains strong, with $16.4 million in cash and $214 million in available borrowing capacity.

• Cautious outlook on China and auto markets due to ongoing uncertainty and potential government shutdown impacts.